Singular Genomics Systems (NASDAQ:OMIC) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.41) by 19.51 percent. This is a 32 percent decrease over losses of $(0.25) per share from the same period last year.
Frontline Announced Earlier Confirmation That It Received From Euronav An Arbitration Request For Proceedings On The Merits Following Frontline’s Decision To Terminate The Combination Agreement
Frontline plc ("Frontline") (NYSE: FRO), formerly Frontline Ltd., confirms that it has received from Euronav NV an arbitration request for proceedings on the merits following Frontline's decision to terminate the combination agreement as further explained in Frontline's press release dated 9 January 2023.
